DECREASED BONE MINERALIZATION IN CHILDREN WITH PHENYLKETONURIA UNDER TREATMENT

Citation
L. Hillman et al., DECREASED BONE MINERALIZATION IN CHILDREN WITH PHENYLKETONURIA UNDER TREATMENT, European journal of pediatrics, 155, 1996, pp. 148-152
Citations number
9
Categorie Soggetti
Pediatrics
ISSN journal
03406199
Volume
155
Year of publication
1996
Supplement
1
Pages
148 - 152
Database
ISI
SICI code
0340-6199(1996)155:<148:DBMICW>2.0.ZU;2-#
Abstract
Children with phenylketonuria (PKU) obtain a great deal of their prote in and mineral intakes from synthetic elemental formulae devoid of phe nylalanine. To assess the effect of such diets and/or the disease on b one mineralization, children with PKU were compared to normal children for many parameters of mineral homeostasis and bone mineralization. A total of 11 children with PKU of mean age 10.9 +/- 4.2 years were com pared to a large group of normal control children mean age 11.4 +/- 4. 2, and an age and sex matched subset (n = 11). Children with PKU had l ower serum calcium (9.1 +/- 0.9 vs 10.4 +/- 1.9 mg/dl P < 0.01) and ma gnesium (1.67 +/- 1.4 vs 2.07 +/- 0.16 mg/dl, P < 0.001) but normal va lues for phosphorus, zinc, and copper. The percentage tubular reabsorp tion of phosphorus was increased in PKU (93 +/- 3% vs 88 +/- 6%, P < 0 .05) suggesting a lower phosphorus intake and/or absorption. Serum 25- hydroxyvitamin D, parathyroid hormone and 1,25 dihydroxyvitamin D were similar in PKU and control children. Serum albumin and lean body mass by dual energy X-ray absorption were not different suggesting that pr otein intake was adequate. In the 11 pairs, a decreased bone mineral d ensity was seen for the lumbar spine (0.61 +/- 0.15 vs 0.72 +/- 0.24 P < 0.05), and lower extremities (1.56 +/- 0.30 vs 1.87 +/- 0.56 P < 0. 05) by paired t-test. Compared to the total controls and the paired co ntrols, decreases were seen in markers of bone formation; bone alkalin e phosphatase, (72 +/- 30 vs 126 +/- 43 P < 0.001), osteocalcin (10.7 +/- 3.4 vs 13.1 +/- 2.0 P < 0.05) and procollagen type I carboxytermin al propeptide. No differences were seen in the bone resorption markers tartrate resistant acid phosphatase and urine Ca/Cr. The changes note d could not be related after age correction to serum phenylalanine lev els, protein intake, or mineral intakes. It is unclear whether deficit s in bone mineralization relate to the disease process itself or its t reatment.